Two Sigma Investments’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Sell |
1,332,761
-101,710
| -7% | -$245K | 0.01% | 1488 |
|
|
2025
Q1 | $3.17M | Buy |
1,434,471
+1,325,052
| +1,211% | +$2.93M | 0.01% | 1368 |
|
|
2024
Q4 | $596K | Sell |
109,419
-163,923
| -60% | -$893K | ﹤0.01% | 2393 |
|
|
2024
Q3 | $2.27M | Buy |
273,342
+19,142
| +8% | +$159K | 0.01% | 1541 |
|
|
2024
Q2 | $1.82M | Sell |
254,200
-239,922
| -49% | -$1.72M | ﹤0.01% | 1551 |
|
|
2024
Q1 | $4.28M | Buy |
494,122
+347,226
| +236% | +$3.01M | 0.01% | 1007 |
|
|
2023
Q4 | $962K | Sell |
146,896
-398,373
| -73% | -$2.61M | ﹤0.01% | 2033 |
|
|
2023
Q3 | $5.45M | Sell |
545,269
-1,817,449
| -77% | -$18.2M | 0.01% | 807 |
|
|
2023
Q2 | $29.4M | Buy |
2,362,718
+560,509
| +31% | +$6.97M | 0.07% | 296 |
|
|
2023
Q1 | $25.2M | Buy |
1,802,209
+245,742
| +16% | +$3.44M | 0.07% | 300 |
|
|
2022
Q4 | $22.3M | Buy |
1,556,467
+1,018,173
| +189% | +$14.6M | 0.07% | 315 |
|
|
2022
Q3 | $13.7M | Sell |
538,294
-83,978
| -13% | -$2.14M | 0.05% | 392 |
|
|
2022
Q2 | $17.7M | Sell |
622,272
-10,649
| -2% | -$303K | 0.06% | 348 |
|
|
2022
Q1 | $22.3M | Buy |
632,921
+226,041
| +56% | +$7.97M | 0.07% | 353 |
|
|
2021
Q4 | $17M | Buy |
406,880
+377,172
| +1,270% | +$15.8M | 0.04% | 469 |
|
|
2021
Q3 | $1.46M | Sell |
29,708
-409,368
| -93% | -$20.1M | ﹤0.01% | 1517 |
|
|
2021
Q2 | $18.3M | Buy |
439,076
+216,870
| +98% | +$9.05M | 0.04% | 443 |
|
|
2021
Q1 | $7.92M | Sell |
222,206
-65,992
| -23% | -$2.35M | 0.02% | 667 |
|
|
2020
Q4 | $8.08M | Buy |
+288,198
| New | +$8.08M | 0.02% | 563 |
|